Disease Free Survival - an overview | ScienceDirect Topics
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Comparison of disease-free survival (A) and overall survival (B) among... | Download Scientific Diagram
![PDF] Clinical endpoints in oncology - a primer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f33163534f9a85acc25579932597eab0cf9e71ff/7-Figure1-1.png "PDF] Clinical endpoints in oncology - a primer. | Semantic Scholar")
PDF] Clinical endpoints in oncology - a primer. | Semantic Scholar
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology
Frontiers | Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder:
Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India
A) Disease-free survival, (B) progression-free survival and (C)... | Download Scientific Diagram
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
図3 Overall and disease-free survival curves of patients with initially unresectable disease who underwent resection after downsizing chemotherapy.
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Overall survival vs disease-free survival and other surrogate endpoints - interpretation - Datamethods Discussion Forum
Overall survival (a) and disease-free survival (b) among the entire... | Download Scientific Diagram
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - ScienceDirect
Kaplan-Meier curves for disease-free survival and overall survival... | Download Scientific Diagram
Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer | Experimental Hematology & Oncology | Full Text
Disease-Free Survival As a Clinical Trial Endpoint: Does It Matter, and to Whom?
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
